The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine

The platelet-activating factor receptor (PAFR) and its ligand (PAF) are important inflammatory mediators that are overexpressed in ovarian cancer. The receptor is an important player in ovarian cancer development. In this study, we aimed to evaluate the prognostic value of PAFR in epithelial ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales: Deuster, Eileen, Hysenaj, Ivi, Kahaly, Maja, Schmoeckel, Elisa, Mayr, Doris, Beyer, Susanne, Kolben, Thomas, Hester, Anna, Kraus, Fabian, Chelariu-Raicu, Anca, Burges, Alexander, Mahner, Sven, Jeschke, Udo, Trillsch, Fabian, Czogalla, Bastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466210/
https://www.ncbi.nlm.nih.gov/pubmed/34571986
http://dx.doi.org/10.3390/cells10092337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466210/
https://www.ncbi.nlm.nih.gov/pubmed/34571986
http://dx.doi.org/10.3390/cells10092337

Ejemplares similares